Literature DB >> 25296251

HIV: A stamp on the envelope.

Rogier W Sanders1, John P Moore2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25296251      PMCID: PMC4836556          DOI: 10.1038/nature13926

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  15 in total

Review 1.  Immunogenicity of HIV-1 envelope glycoprotein oligomers.

Authors:  Mattias N E Forsell; William R Schief; Richard T Wyatt
Journal:  Curr Opin HIV AIDS       Date:  2009-09       Impact factor: 4.283

2.  Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus.

Authors:  Jason S McLellan; Man Chen; M Gordon Joyce; Mallika Sastry; Guillaume B E Stewart-Jones; Yongping Yang; Baoshan Zhang; Lei Chen; Sanjay Srivatsan; Anqi Zheng; Tongqing Zhou; Kevin W Graepel; Azad Kumar; Syed Moin; Jeffrey C Boyington; Gwo-Yu Chuang; Cinque Soto; Ulrich Baxa; Arjen Q Bakker; Hergen Spits; Tim Beaumont; Zizheng Zheng; Ningshao Xia; Sung-Youl Ko; John-Paul Todd; Srinivas Rao; Barney S Graham; Peter D Kwong
Journal:  Science       Date:  2013-11-01       Impact factor: 47.728

3.  Crystal structure of a soluble cleaved HIV-1 envelope trimer.

Authors:  Jean-Philippe Julien; Albert Cupo; Devin Sok; Robyn L Stanfield; Dmitry Lyumkis; Marc C Deller; Per-Johan Klasse; Dennis R Burton; Rogier W Sanders; John P Moore; Andrew B Ward; Ian A Wilson
Journal:  Science       Date:  2013-10-31       Impact factor: 47.728

4.  Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

Authors:  Rogier W Sanders; Mika Vesanen; Norbert Schuelke; Aditi Master; Linnea Schiffner; Roopa Kalyanaraman; Maciej Paluch; Ben Berkhout; Paul J Maddon; William C Olson; Min Lu; John P Moore
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody.

Authors:  Per Johan Klasse
Journal:  Virology       Date:  2007-09-07       Impact factor: 3.616

6.  Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.

Authors:  Rajesh P Ringe; Rogier W Sanders; Anila Yasmeen; Helen J Kim; Jeong Hyun Lee; Albert Cupo; Jacob Korzun; Ronald Derking; Thijs van Montfort; Jean-Philippe Julien; Ian A Wilson; Per Johan Klasse; Andrew B Ward; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

7.  Targeting B-cell germlines and focusing affinity maturation: the next hurdles in HIV-1-vaccine development?

Authors:  Max Medina-Ramírez; Rogier W Sanders; Per Johan Klasse
Journal:  Expert Rev Vaccines       Date:  2014-04       Impact factor: 5.217

8.  Structure and immune recognition of trimeric pre-fusion HIV-1 Env.

Authors:  Marie Pancera; Tongqing Zhou; Aliaksandr Druz; Ivelin S Georgiev; Cinque Soto; Jason Gorman; Jinghe Huang; Priyamvada Acharya; Gwo-Yu Chuang; Gilad Ofek; Guillaume B E Stewart-Jones; Jonathan Stuckey; Robert T Bailer; M Gordon Joyce; Mark K Louder; Nancy Tumba; Yongping Yang; Baoshan Zhang; Myron S Cohen; Barton F Haynes; John R Mascola; Lynn Morris; James B Munro; Scott C Blanchard; Walther Mothes; Mark Connors; Peter D Kwong
Journal:  Nature       Date:  2014-10-08       Impact factor: 49.962

9.  A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

Authors:  Rogier W Sanders; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Anila Yasmeen; Natalia de Val; Helen J Kim; Claudia Blattner; Alba Torrents de la Peña; Jacob Korzun; Michael Golabek; Kevin de Los Reyes; Thomas J Ketas; Marit J van Gils; C Richter King; Ian A Wilson; Andrew B Ward; P J Klasse; John P Moore
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

Review 10.  Why HIV virions have low numbers of envelope spikes: implications for vaccine development.

Authors:  John Schiller; Bryce Chackerian
Journal:  PLoS Pathog       Date:  2014-08-07       Impact factor: 6.823

View more
  16 in total

1.  Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes.

Authors:  Steven W de Taeye; Gabriel Ozorowski; Alba Torrents de la Peña; Miklos Guttman; Jean-Philippe Julien; Tom L G M van den Kerkhof; Judith A Burger; Laura K Pritchard; Pavel Pugach; Anila Yasmeen; Jordan Crampton; Joyce Hu; Ilja Bontjer; Jonathan L Torres; Heather Arendt; Joanne DeStefano; Wayne C Koff; Hanneke Schuitemaker; Dirk Eggink; Ben Berkhout; Hansi Dean; Celia LaBranche; Shane Crotty; Max Crispin; David C Montefiori; P J Klasse; Kelly K Lee; John P Moore; Ian A Wilson; Andrew B Ward; Rogier W Sanders
Journal:  Cell       Date:  2015-12-17       Impact factor: 41.582

2.  A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.

Authors:  Pavel Pugach; Gabriel Ozorowski; Albert Cupo; Rajesh Ringe; Anila Yasmeen; Natalia de Val; Ronald Derking; Helen J Kim; Jacob Korzun; Michael Golabek; Kevin de Los Reyes; Thomas J Ketas; Jean-Philippe Julien; Dennis R Burton; Ian A Wilson; Rogier W Sanders; P J Klasse; Andrew B Ward; John P Moore
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

3.  HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike.

Authors:  Dirk Eggink; Steven W de Taeye; Ilja Bontjer; Per Johan Klasse; Johannes P M Langedijk; Ben Berkhout; Rogier W Sanders
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

4.  The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region.

Authors:  Beatriz Apellániz; Edurne Rujas; Soraya Serrano; Koldo Morante; Kouhei Tsumoto; Jose M M Caaveiro; M Ángeles Jiménez; José L Nieva
Journal:  J Biol Chem       Date:  2015-03-18       Impact factor: 5.157

5.  Reduced Susceptibility to VIRIP-Based HIV-1 Entry Inhibitors Has a High Genetic Barrier and Severe Fitness Costs.

Authors:  Janis A Müller; Anna Glöckle; Ali Gawanbacht; Matthias Geyer; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 6.  HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies.

Authors:  Steven W de Taeye; John P Moore; Rogier W Sanders
Journal:  Trends Immunol       Date:  2016-02-09       Impact factor: 16.687

7.  Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer.

Authors:  Ronald Derking; Gabriel Ozorowski; Kwinten Sliepen; Anila Yasmeen; Albert Cupo; Jonathan L Torres; Jean-Philippe Julien; Jeong Hyun Lee; Thijs van Montfort; Steven W de Taeye; Mark Connors; Dennis R Burton; Ian A Wilson; Per-Johan Klasse; Andrew B Ward; John P Moore; Rogier W Sanders
Journal:  PLoS Pathog       Date:  2015-03-25       Impact factor: 6.823

8.  Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes.

Authors:  Rajesh Kumar; Gabriel Ozorowski; Vivek Kumar; Lauren G Holden; Tripti Shrivastava; Shilpa Patil; Suprit Deshpande; Andrew B Ward; Jayanta Bhattacharya
Journal:  J Biol Chem       Date:  2017-07-25       Impact factor: 5.157

9.  Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization.

Authors:  Alba Torrents de la Peña; Jean-Philippe Julien; Steven W de Taeye; Fernando Garces; Miklos Guttman; Gabriel Ozorowski; Laura K Pritchard; Anna-Janina Behrens; Eden P Go; Judith A Burger; Edith E Schermer; Kwinten Sliepen; Thomas J Ketas; Pavel Pugach; Anila Yasmeen; Christopher A Cottrell; Jonathan L Torres; Charlotte D Vavourakis; Marit J van Gils; Celia LaBranche; David C Montefiori; Heather Desaire; Max Crispin; Per Johan Klasse; Kelly K Lee; John P Moore; Andrew B Ward; Ian A Wilson; Rogier W Sanders
Journal:  Cell Rep       Date:  2017-08-22       Impact factor: 9.423

10.  A diverse collection of B cells responded to HIV infection in infant BG505.

Authors:  Cassandra Simonich; Mackenzie M Shipley; Laura Doepker; Theodore Gobillot; Meghan Garrett; Evan M Cale; Brianna Hennessy; Hannah Itell; Vrasha Chohan; Nicole Doria-Rose; Ruth Nduati; Julie Overbaugh
Journal:  Cell Rep Med       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.